Drug information [electronic resource] : a guide for pharmacists / [edited by] Patrick M. Malone, Karen L. Kier, John E. Stanovich, Meghan J. Malone.

"A Lange medical book."

Includes bibliographical references and indexes.

Chapter 1: Introduction to the Concept of Drug Information -- Chapter 2: Formulating Effective Responses and Recommendations: A Structured Approach -- Chapter 3: Drug Information Resources -- Chapter 4: Drug Literature Evaluation I: Controlled Clinical Trial Evaluation -- Chapter 5: Literature Evaluation II: Beyond the Basics -- Chapter 6: Pharmacoeconomics -- Chapter 7: Evidence-Based Clinical Practice Guidelines -- Chapter 8: The Application of Statistical Analysis in the Biomedical Sciences -- Chapter 9: Professional Writing -- Chapter 10: Legal Aspects of Drug Information Practice -- Chapter 11: Ethical Aspects of Drug Information Practice -- Chapter 12: Pharmacy and Therapeutics Committee -- Chapter 13: Drug Evaluation Monographs -- Chapter 14: Quality Improvement and the Medication Use System -- Chapter 15: Medication Misadventures I: Adverse Drug Reactions -- Chapter 16: Medication Misadventures II: Medication and Patient Safety -- Chapter 17: Investigational Drugs -- Chapter 18: Policy Development, Project Design, and Implementation -- Chapter 19: Drug Information in Ambulatory Care -- Chapter 20: Drug Information and Contemporary Community Pharmacy Practice -- Chapter 21: Drug Information Education and Training -- Chapter 22: Pharmaceutical Industry and Regulatory Agency Drug Information -- Chapter 23: Assessing Drug Promotions -- Chapter 24: Pharmacy Informatics: Enabling Safe and Efficacious Medication Use -- Glossary -- Answers for Case Studies -- Appendices -- 2–1: Appendix 2–1 Drug Consultation Request Form -- 2–2: Appendix 2–2 Examples of Questions for Obtaining Background Information from Requestors -- 3–1: Appendix 3–1 Performing a Pubmed Search -- 3–2: Appendix 3–2 Selected Primary Literatures Sources -- 4–1: Appendix 4–1 Questions for Assessing Clinical Trials -- 5–1: Appendix 5–1 Beyond the Basics: Questions to Consider for Critique of Primary Literature -- 7–1: Appendix 7–1 Grade Evidence Profile: Antibiotics for Children with Acute Otitis Media -- 9–1: Appendix 9–1 Question Example -- 9–2: Appendix 9–2 Abstracts -- 9–3: Appendix 9–3 Bibliography -- 11–1: Appendix 11–1 Code of Ethics for Pharmacists -- 12–1: Appendix 12–1 Pharmacy and Therapeutics Committee Procedure -- 12–2: Appendix 12–2 Formulary Request Form -- 12–3: Appendix 12–3 P&T Committee Meeting Attributes -- 12–4: Appendix 12–4 Example P&T Committee Minutes -- 12–5: Appendix 12–5 Chairperson Skills -- 12–6: Appendix 12–6 Conflict-of-Interest Declaration -- 13–1: Appendix 13–1 Format for Drug Monograph -- 13–2: Appendix 13–2 Example Drug Monograph -- 14–1: Appendix 14–1 Tools Used in Quality Assurance -- 14–2: Appendix 14–2 Example of Criteria and Request for Approval -- 14–3: Appendix 14–3 Example of MUE Results -- 14–4: Appendix 14–4 Evaluation Form for Drug Information Response -- 15–1: Appendix 15–1 Kramer Questionnaire -- 15–2: Appendix 15–2 Naranjo Algorithm -- 15–3: Appendix 15–3 Jones Algorithm -- 15–4: Appendix 15–4 MedWatch Form -- 17–1: Appendix 17–1 Investigational New Drug Application -- 17–2: Appendix 17–2 Statement of Investigator -- 17–3: Appendix 17–3 Protocol Medication Economic Analysis -- 17–4: Appendix 17–4 Investigational Drug Accountability Record -- 18–1: Appendix 18–1 Policy Example: High-Alert Medications -- 18–2: Appendix 18–2 Policy Example: Medication Shortages and Backorders -- 22–1: Appendix 22–1 Response Letter Drug A—Incidence of Yellow Stripes.

This trusted guide teaches students and professionals how to research, interpret, evaluate, collate, and disseminate drug information in the most effective and efficient manner possible.

Also issued in online and PDF version.

Description based on cover image and table of contents, viewed on Oct. 24, 2016.